ERYTECH Pharma Voting Results by Resolution from Annual General Meeting Held on June 21, 2019 Post author:admERY Post published:July 4, 2019 Post category:Newsroom You Might Also Like ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018 ERYTECH Presents New Data on GRASPA’s Mechanism of Action at ASH Annual Meeting December 1, 2016 ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases February 8, 2022
ERYTECH to Present Pharmacodynamic Data from Phase 2/3 Trial of Eryaspase in ALL at ASCO 2018 June 4, 2018
